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Transport Rate = f ( Km, Vmax, Ppassive )
＜Impact of P-gp on in vivo Oral Drug Absorption＞
Development of kinetic model that can predict the in vivo
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Various cell lines with different expression levels of P-gp
cell line
Protein (µg/cm2)
2　　Normal Caco-2 cells 26.8 3.22
3　　P-gp-induced Caco-2 cells 103.7 5.20
4　　P-gp-highly induced Caco-2 cells 191.0 9.53




MDR1-knockdown Caco-2 cells5 1.328.71
Protein levels were detected and quantified by Western blotting, loading total protein of 50µg for cells and standard.
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Effect of donor (apical) concentration
on AP to BL transport of P-gp substrates
in various cell monolayers
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Donor concentration to Apical (µM)
Digoxin





































CLp = CLpmax – CLP-gp
CLp-gp = Vmax / (Km(app) + Ca)
Sigmoid Emax model








To add the flexibility, Hill Coefficient (r) was introduced to Sigmoid Emax model
Estimation of Km(app) , Vmax and hill coefficient of three




























































































Why does “Km(app)” value fluctuate depending 











Drug  concentration at drug binding-
site of P-gp increase easily when the 
apical concentration become high.
Drug  concentration at drug binding-
site of P-gp is kept low even when the 
apical concentration become high.
Correlation between P-gp expression level 


















































Correlation between P-gp expression level 







































How to estimate P-gp-mediated efflux in human intestine?
How to predict the permeability in human intestine?



















P-gp expression level 
in human intestine
(1) Passive permeability  :  
Possible to be predicted from Caco-2 
data by using P-gp inhibitor.
(2) P-gp mediated efflux  :
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Regional difference in P-gp expression levels 
in rat small intestine (proximal and distal)
7















Protein levels were detected and quantified by Western blotting, loading 100µg for rat BBM; 50µg for standard.
Estimation of “Vmax” and “Km(app)” values of quinidine














































Passive permeability “Papp” of quinidine















Papp of quinidine to rat 
small intestine was 

















































Simulation of concentration-dependent permeability of 
quinidine in rat small intestine (proximal and distal)
Experimental


















(x10-5 L/min /10cm gut)
Simulation of concentration-dependent permeability of 
verapamil in rat small intestine (proximal and distal)
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Distal













































Simulation of concentration-dependent permeability of 
vinblastine in rat small intestine (proximal and distal)
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“Sigmoid Emax model” for permeability-concentration curve of 
P-gp substrate drugs can provide the fundamental parameters of 
P-gp-mediated transport, Km(app) and Vmax. 
Km(app) , Vmax
Passive permeability
This study clearly demonstrated the possibility to estimate Km(app)
and Vmax values in human intestine from P-gp expression level and 
to predict concentration-dependent permeability of P-gp substrate 
















Permeability-concentration curve of P-gp substrate drugs can 
predict how P-gp affect the pharmacokinetic profiles of its drugs 
and how much permeability of its drugs will be changed by dose 
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